Konniseri Pharmaceuticals Private Limited, a active private limited company, was established on 06 February 2017 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239KA2017PTC099699. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 11 professional, Its leadership includes Aurelia Narayan (Director), Shankar Usha (Additional Director). Past directors included Krishnan Akhilesh Narayan, Jayanthi Krishnan, Nagendra Ranganatha Rao Keshavara. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at Sy No.111, Rm No.1, Sri Adithya Arcade 2Nd Floor,Kundalahalli, Bangalore, Karnataka, 560037.
U24239KA2017PTC099699
099699
06 February 2017
₹1.00 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Konniseri Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aurelia Narayan | Director | 30 Nov 2018 | Current |
| Shankar Usha | Additional Director | 15 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Apr 2025 | Past |
| Pramod Abcsdd | Director | 11 Jul 2018 | Past |
| Pramod Abcsdd | Additional Director | 05 Dec 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Konniseri Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 1041.15% increase. The company also saw a substantial fall in profitability, with a 861.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1515.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Konniseri Pharmaceuticals had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Konniseri Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Konniseri Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Konniseri Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shankar Usha was appointed as a Additional Director was appointed as a Additional Director on 15 Apr 2025 & has been associated with this company since 8 months 4 days . was completed.
Progress on Konniseri Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.
The activity Konniseri Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Bangalore. was completed.
The activity Aurelia Narayan was appointed as a Director was appointed as a Director on 30 Nov 2018 & has been associated with this company since 7 years 19 days . was completed.
Progress on Konniseri Pharmaceuticals Private Limited was registered on 06 Feb 2017 with Roc Bangalore & aged 8 years 10 months as per MCA records. was documented.
The CIN of Konniseri Pharmaceuticals Private Limited is U24239KA2017PTC099699.
Konniseri Pharmaceuticals Private Limited is headquartered at Sy No.111, Rm No.1, Sri Adithya Arcade 2Nd Floor,Kundalahalli, Bangalore, Karnataka, 560037.
Konniseri Pharmaceuticals Private Limited was incorporated on 06 February 2017.
The current directors of Konniseri Pharmaceuticals Private Limited are
The primary industry of Konniseri Pharmaceuticals Private Limited is Pharma.
Konniseri Pharmaceuticals Private Limited is unlisted.
The authorized capital of Konniseri Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Konniseri Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX